Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by N0taP00pon May 05, 2023 6:48pm
214 Views
Post# 35434052

RE:RE:RE:RE:RE:Finances

RE:RE:RE:RE:RE:FinancesWhen Medtronic gave TMDI (a Canadian robotic surgery startup with a very promising design but desperate for money)  $10M, everyone was excited that it was the beginning of a future JV or buyout of some kind. But it ended up that Medtronic only wanted some IP for their own platform. There was a temporary spike in share price but that's where it ended. TMDI was supposed to be some kind of supplier to Medtronic but I don't know what happened to that strategy. TMDI is basically struggling to survive and trading at ~ 12 cents. Needless to say I lost money.   So if TLTFF does get into a JV, I hope they pull off a much better deal from a position of strength, which would only come once they get BTD approval. The longer it takes, the more desperate the situation becomes. 
<< Previous
Bullboard Posts
Next >>